Adrenaline Injections to Children Born at Elective CS
Information source: Hvidovre University Hospital
ClinicalTrials.gov processed this data on August 20, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Respiratory Distress; Hypoglycemia
Intervention: Adrenaline (Drug)
Phase: N/A
Status: Completed
Sponsored by: Hvidovre University Hospital Official(s) and/or principal investigator(s): Lene A Olsen, M.D., Principal Investigator, Affiliation: Hvidovre University Hospital, Copenhagen, Kettegaards allé 30, 2650 Hvidovre, DK Pernille Pedersen, Principal Investigator, Affiliation: Hvidovre University Hospital
Summary
Children born after elective C-section have a greater risk of respiratory problems and
hypoglycemia - most likely due to a lower concentration of stress hormones compared to
children born vaginally. Hypothesis: can we eliminate or reduce the risk of respiratory
distress and hypoglycaemia by administrating adrenaline to the newborn.
Clinical Details
Official title: Can the Risk of RD and Hypoglycemia in Children Born at Elective CS be Reduced by Injection of Adrenaline
Study design: Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Double-Blind, Primary Purpose: Prevention
Primary outcome: respiratory distresshypoglycemia
Eligibility
Minimum age: N/A.
Maximum age: 1 Day.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- All children born at elective section with gestational age more than 37 + 0
Exclusion Criteria:
- Children in whom a serious malformation was found during pregnancy assuming this
malformation will lead to very early death or respiratory problems.
- Serious malformations (ex. anencephalia) will be excluded at birth
- Other malformations will be estimated by investigator whether it will lead to
exclusion.
Locations and Contacts
Hvidovre University Hospital, Copenhagen, Hvidovre 2650, Denmark
Hvidovre Hospital, KettegÄrd Alle 31, Hvidovre 2650, Denmark
Additional Information
Related publications: Irestedt L, Lagercrantz H, Belfrage P. Causes and consequences of maternal and fetal sympathoadrenal activation during parturition. Acta Obstet Gynecol Scand Suppl. 1984;118:111-5.
Starting date: June 2006
Last updated: June 27, 2007
|